Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06311045 · ClinicalTrials.gov registry record · NA

Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)

A NA study of Obstructive Sleep Apnea, sponsored by NYU Langone Health.

Active
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT06311045 is a NA study of Obstructive Sleep Apnea that is active but no longer recruiting, run by NYU Langone Health. The registered enrollment target is 14 participants, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06311045, a NA study of Obstructive Sleep Apnea, is active but no longer recruiting, sponsored by NYU Langone Health.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial (RCT) of 4 weeks of study supplement N-acetylcysteine (NAC) versus placebo in persons with significant obstructive sleep apnea (OSA) who are receiving positive airway pressure therapy (PAP), the standard of care therapy. The purpose of the study is to determine if NAC is associated with sex-specific changes in overnight oxidative stress, inflammation, as well as endothelial dysfunction in persons with OSA.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT N-acetylcysteine (NAC)
  • PROCEDURE Positive Airway Pressure (PAP) Therapy

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2024-05-07
Est. Completion 2026-04
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT06311045

The ClinicalTrials.gov registry entry for NCT06311045 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 221-participant average among 155 other Obstructive Sleep Apnea trials with a reported enrollment target (94% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obstructive Sleep Apnea appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT06311045 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT06311045 about?

NCT06311045 is a clinical study titled "Obstructive Sleep Apnea (OSA) and Sex-Specific Responses to N-acetylcysteine (NAC)". This is a randomized controlled trial (RCT) of 4 weeks of study supplement N-acetylcysteine (NAC) versus placebo in persons with significant obstructive sleep apnea (OSA) who are receiving positive airway pressure therapy (PAP), the standard of care therapy. The purpose of the study is to determine ...

What is the current status of trial NCT06311045?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 14 participants. The study started on 2024-05-07. Estimated completion is 2026-04.

What conditions does trial NCT06311045 study?

This clinical trial studies the following conditions: Obstructive Sleep Apnea.

What interventions are being tested in trial NCT06311045?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), N-acetylcysteine (NAC) (DIETARY_SUPPLEMENT), Positive Airway Pressure (PAP) Therapy (PROCEDURE).

Who is sponsoring clinical trial NCT06311045?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06311045 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obstructive Sleep Apnea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.